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Background:During aproper execution of dMLCplans, there occurs anundesired but frequent
effect of the dose locally accumulated by tissue being signiﬁcantly different than expected.
The conventional dosimetric QA procedures give only a partial picture of the quality of IMRT
treatment, because their solely quantitative outcomes usually correspond more to the total
area of the detector than the actually irradiated volume.
Aim: The aim of this investigation was to develop a procedure of dynamic plans veriﬁcation
which would be able to visualize the potential anomalies of dose distribution and specify
which tissue they exactly refer to.
Materials & methods: The paper presents a method discovered and clinically examined in our
department. It is based on a Gamma Evaluation concept and allows accurate localization
of deviations between predicted and acquired dose distributions, which were registered by
portal as well as ﬁlm dosimetry. All the calculations were performed on the self-made soft-
ware GammaEval, the -images (2-dimensional distribution of -values) and -histograms
were created as quantitative outcomes of veriﬁcation.Results: Over 150 maps of dose distribution have been analyzed and the cross-examination
of the gamma images with DRRs was performed.
Conclusions: It seems, that the complex monitoring of treatment would be possible owing to
as a
landthe images obtained
© 2010 Greater Po
. Background
lthough the IMRT was ﬁrst implemented into the clinical
ractise several years ago and many papers have ever since
een published on dynamic plans veriﬁcation, it is still unclear
hy the local dose deviations between predicted and acquired
ose distribution are observed.1 It is believed that only the
re-treatment control of actually generated ﬂuence is able to
rovide essential information about the quality of irradiation.
sually, it is limited to dosimetric veriﬁcation which is typ-
cally performed using the gamma evaluation method.2–4 As
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oi:10.1016/j.rpor.2010.11.001cross-examination of -images and corresponding DRRs.
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a result of the comparison between the acquired dose distri-
bution and the predicted one, the matrix of (r) is obtained.
The measurement point r passes the criteria of correctness
if (r) ≤ 1. A quantitative estimation of dose delivery is pos-
sible owing to -histograms which combine the information
about a -index value with that of the area of corresponding
part of the ﬁeld.5,6 In our previous paper,7 we discussed the
difference between the global gamma conception and its vari-
ety, local gamma, when the acceptable dose deviation (Dmax)
was proportional to the expected dose value D(rc) for each ele-
ment of the calculated dose matrix rc. The advantages and
disadvantages of both approaches have been presented.
Sometimes, quantitative outcomes of dynamic plans veri-
ﬁcation performed by commercial instruments (score, average
. Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved.
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Fig. 1 – Exemplary results of gamma evaluation obtained with Portal Dosimetry (Varian). (a) -Image and (b) quantitative
outcomes.
gamma and -histograms) correspond to the total area of
detector matrix or its regular, usually rectangular part, rather
than the actually irradiated volume (ﬁeld area). It makes the
veriﬁcation outputs hard to use and imprecise. See exemplary
results presented in Fig. 1. The average gamma reported by the
system for presented ﬁeld is about 0.096, even though only a
small number of points (marked in white colour) correspond
to  <0.096. The underestimation of the parameter was possi-
ble, because the statistical report had been prepared for a total
matrix of EPID and the unexposed points, which in fact do not
belong to the ﬁeld, had not been excluded. We believe that
the key to obtain more reliable and useful outcomes of IMRT
veriﬁcation is to specify precisely the area of interest (deﬁne a
border of therapeutic ﬁeld).
The conventional solution based on the gamma approach
shows the level of local dose variations only, which is certainly
very important from the dosimetric point of view, but is in fact
unable to localise irregularities or specify what kind of tissue
they refer to. It will be demonstrated in this paper that the
fusion of -image (graphical representation of -matrix) and
corresponding DRR for each ﬁeld is a sufﬁcient procedure toestimate the process of speciﬁed organs irradiation (especially
target and organs at risk) during IMRT treatment.
2. Aim
The aim of this investigation was to develop an IMRT ver-
iﬁcation procedure based on the Gamma Evaluation. When
developed, the procedure could demonstrate how the differ-
ences in actual and expected dose distribution correspond to
the target volume and organs at risk. Precise speciﬁcation of
therapeutic ﬁeld borders makes the quantitative outcomes of
veriﬁcation more reliable.
3. Materials and methods
In our radiotherapy department the gamma evaluation
method was adapted to dynamic plans veriﬁcation in 2002.
The IMRT treatment plans are preparedusing the Eclipse treat-
ment planning system (VarianMedical Systems Inc., Palo Alto,
CA) and Varian linear accelerators (2300CD and 23Ex) with
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Fig. 2 – Therapeutic ﬁeld border calculation: (a) static MLC
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Fig. 3 – Superposition of portal-acquired images for3D CRT) and (b) dynamic MLC (IMRT-sliding window).
ark II 80MLC and Millennium 80MLC collimators are used
or treatments. The gamma veriﬁcationwas executed for each
herapeutic ﬁeld and the portal dosimetry (Varian aS500) and
lms (Kodak X-Omat V) were applied for intensity ﬂuence
ecording.8,9
The traditional comprehension of therapeutic ﬁeld border
50% of maximum dose in a total plane perpendicular to beam
xis following 3D CRTs example) could entail the loss of infor-
ation about part of the IMRT ﬁeld, because of the intentional
iversiﬁcation of dose distribution. To have an undistorted
iew of plan delivery, the (Dmin) criterion has to be reduced,
owever, it is difﬁcult to deﬁne its correct value.
It must be emphasized that there is a difference between
he method of determining a static ﬁeld aperture and IMRTMultiple Carriage Group Field.
ﬁeld, when dynamic mode of MLC is in operation. When the
border of the static ﬁeld is calculated, the system is looking
for the farthest point from the centre of the ﬁeld which accu-
mulates no less than Dmin and no direction is preferred. To
obtain the contour of the ﬁeld generated by dMLC, the proce-
dure is performed along the leaves direction only and much
more regular shape is obtained (compare Fig. 2).
Depending on the spatial dimension of the ﬂuence which
is being created, it is sometimes necessary to split the deliv-
ery into two or even three partially overlapping subﬁelds.
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Fig. 4 – Transformation of DRR image. (a) Vertical
translation: S – source, SDD – source-detector distance, SAD
– distance from source to the plane where DRR image is
created and (b) DRR rotation: x′, y′, z′ – gamma image’
coordination system and x, y, z – DRR image’ coordination
system.
Fig. 5 – Cumulative histograms of -value vs. corresponding ﬁeldadiotherapy 1 6 ( 2 0 1 1 ) 1–9
Veriﬁcation of this kind of ﬁelds (MCG – multiple carriage
group ﬁelds) is more complicated than single carriage group
ﬁelds (SCG), especially when portal imager is in operation. The
treatment management system (Varis/Aria in the case of Var-
ian radiotherapy solution) stores the portal-acquired images
whenever a beam-off signal occurs. Using the Portal Dosime-
tryworkspace (Varian/Eclipse), examination can be performed
only for each subﬁeld independently. This approach could
entail the loss of information about the resultant dose devi-
ations in overlapping parts of the subﬁelds. We propose to
sum up dose distributions corresponding to each subﬁeld to
obtain a global imageof a treatmentﬁeld. Theprocedurehas to
be performed for both predicted and acquired portal images.
The effective (measured) dose distribution is simply created
by summing up the EPID readings for all subﬁelds. However,
when creating the predicted (resultant) portal image, only rel-
ative dose distributions are available for exporting from TPS.
Due to the limitation, the contribution of separate subﬁelds,
which is simply proportional to the number of theirMUs,must
be taken into consideration when the expected dose distri-
bution for a total therapeutic ﬁeld is being calculated. The
approach has been presented in Fig. 3.
Over 150 maps of dose distribution have recently been pre-
cisely analysedusing gammaevaluation: 52maps of SCGﬁelds
and 104 maps of MCG ﬁelds. To determine optimal value of
the parameter deﬁning a border of IMRT ﬁeld, a set of gamma
analyses has been performed for each map. We have been
observing a correlation between results of -examination and
the value of Dmin which has been changing from 50% down to
10% of maximal dose in the total plane perpendicular to the
beam axis (Dˆmax). The investigation let us come to the conclu-
sion that Dmin should be valued for each ﬁeld independently.
The value depends on ﬁeld characteristics (level of intensity
modulation) and only one question has to be answered before
the calculation starts: How many of all irradiated points in a
total plane perpendicular to the beam axis have to be taken
under consideration to get the full information about the qual-
area for different values of Dmin: (a) SCG and (b) MCG.
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Fig. 6 – The ratio of ﬁeld area which does not pass the
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Fig. 7 – Average histograms obtained for Dmin calculated
independently for each ﬁeld (standard deviation outlined) –riteria of correctness ( >1) for different values of Dmin
standard deviation outlined).
ty of a dMLC ﬁeld? What is the area of interest? We have
ssumed that no less than 80% (CR – cover ratio) of all irra-
iated points must be taken under consideration, to have a
eliable overview of ﬁeld execution.
First step of border drawing is to estimate the highest dose
ithin the ﬁeld (Dˆmax) – in our solution, only 2% of points
xceed this value. The total area of the ﬁeld S0 and its contour
re obtained for Dmin = 0.02 × Dˆmax, due to the disregard for
he inﬂuence of noise. The value of Dmin is then successively
Fig. 8 – Examples of fusion images obtained for head trecompare Fig. 5.
increasing and the action is stopped when:
S(Dmin)
S0
× 100% = CR ± 1%, (1)where S(Dmin) is the area of the ﬁeld corresponding to Dmin
and CR is deﬁned arbitrarily by the user.
atments: (a–c) brain tumour; (d–f) face skin tumour.
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ffere
dingFig. 9 – Exemplary results of veriﬁcation obtained for two di
and (b) the cross-examination of -image and the correspon
The comparison of the dose plane measured on the treat-
ment unit with the expected dose distribution is performed
on the self-made GammaEval software based on a gamma
algorithm.7 Distance-to-agreement (DTA) and acceptable dose
deviation (Dmax) are set at 3mm and 3.3% of the local dose.
As a result of the comparison, a 2-D matrix of -values is
obtained for each ﬁeld, which is typically to a coloured -
image transformed and then the histograms, which combine
the -index value with area of corresponding part of ﬁeld,
are created.
To estimate the dose accumulated by speciﬁed tissues and
localise hypothetical irregularities (against a background of
body structures), the cross-examination of the -image with
DRR is performed.10 The algorithm employs the original DRRs
which are created by the treatment planning system on the
basis of patient’s CT examination. The images are exported
from the Eclipse using Dicom RT ﬁle format and have to be
converted to ASCII before use. The GammaEval software thennt H&N ﬁelds: (a) cumulative histograms of -index value
DRR.
translates the -image into the isocentrical plane, where the
DRR was created – see Fig. 4a.
Due to a simpliﬁcation, which is typically made during
intensity ﬂuence registration on a treatment unit (reset of
collimator settings), the -image has to be rotated to stay in
the same coordination system with a corresponding DRR (see
Fig. 4b). As an optional result of veriﬁcation the -diagrams
used to be created. They present the correlation between -
index value and the expected dose or the deviation of dose,
which is observed.
4. ResultsOur investigation shows that the quantitative outcomes of -
examination are strongly determined by the value of dose,
which deﬁnes the contour of the IMRT ﬁeld. Regardless of
the number of subﬁelds, the results of veriﬁcation are getting
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Fig. 10 – The -diagrams combining the -value with thereports of practical oncology a
etter while the value of Dmin is going higher, however, the
utcomes obtained for single carriage group ﬁelds are always
etter than the results formultiple carriage groupﬁelds (Fig. 5).
he ratio of ﬁeld area, which does not pass the criteria of cor-
ectness ( >1) for different values of Dmin, is shown in Fig. 6.
n the case of SCG ﬁelds, average results are always about 8%
etter than the outcomes obtained for MCG ﬁelds. We have
bserved for both types of dose delivery that the ﬁeld area
orresponding to  =1 is about 8% smaller for Dmin = 0.5 · Dˆmax
han for Dmin = 0.1 · Dˆmax.
We have furthermore performed the veriﬁcation using ﬁeld
order calculated independently for each ﬁeld where CR=80%
as assumed – Fig. 7 presents averaged results obtained for
his approach. We observed that the mean histogram of -
alue obtained, when the value of Dmin had been calculated
ndependently for every ﬁeld, looks similar to the average his-
ogram obtained for Dmin = 0.2 · Dˆmax (compare Fig. 5).
In our clinical practice, the IMRT technique is usually used
or brain, head & neck and sometimes also for prostate treat-
ents. Depending on the type of tumour and its volume
he cross-examination of -images and DRRs would bring
ssential information about target irradiation and dose accu-
ulated by critical organs situated very close to the tumour.
ig. 8 presents typical results of the fusion for the most fre-
uently cured locations. When head (face region) or brain
reatments are performed, not only the dose accumulated
y eyeball, lenses and optical nerve needs to be controlled.
wing to the fusion-images, we have the possibility to mon-
tor the dose absorbed by respiratory system, paranasal
inuses, glands and other non speciﬁed tissues (compare
ig. 8a–f).
The cross-examination of the images is a very useful
nstrument in the case of head & neck radiotherapy, when the
ose to spinal-cord is a critical parameter of the treatment.
ig. 9 presents two examples of H&N treatments examination
erformed in our department. Therewasnot a great difference
etween quantitative outcomes of -veriﬁcation observed for
hem: about 20% of the total number of points within the ﬁeld
calculated for Dmin = 0.2 · Dˆmax) have not passed the criteria
f correctness. However, the cross-examination showed that
he dose deviations were positioned in very different places.
ue to the observation that the dose exceeds expected value
nly for the target and non critical tissues the treatment of
Patient B” could be initiated (compare Fig. 9b). Otherwise the
-index will not provide the knowledge about the character
f dose deviation, but will inform only of aberration’s ampli-
ude. The missing information is given by -diagrams which
ombine the value of the -index with the corresponding dose
ifference (Fig. 10).
When prostate treatment was performed (typically SCG
elds), we observed that more than 90% of points within
he ﬁeld (for Dmin = 0.2 · Dˆmax) passed the criteria of correct-
ess. Unfortunatelywe are afraid that the procedure described
bove is actually unable to sufﬁciently monitor the quality
f prostate treatment, because the real position of the tar-
et and organs-at-risk (bladder) is not strictly limited to bone
tructures, which are visible in DRR. Similarly, the gamma-
esults obtained for the breast-trial IMRT usually do not
ive a clear idea of the precision of the treatment (consider
ig. 11a and 13b).corresponding deviation of dose: (a) 2D-view and (b)
3D-view.
The consequence of veriﬁcation with the -parameter cal-
culated locally7 are the high values of it usually obtained for
points where a very low dose was expected (e.g. air cavities
and discontinuities of the body). Dose deviations occur in this
situation very often, ﬁrstly, because the leaves move faster to
minimize the time of exposure and secondly – the big differ-
ence of speed between two adjacent leavesmakes the “tongue
and groove” effect much more possible. Fig. 12 presents an
example of H&N treatment with a collimator rotation equal to
90◦. Observe signiﬁcant irregularities in the peripheral part of
the ﬁeld (left and right side of the ﬁeld, above the collarbone).
However, the quantitative outcomes of veriﬁcation were rel-
atively bad, the cross-examination of DRR and the -image
showed that most of the errors were located outside the body
and will not affect the success of radiotherapy.
A special attention has also to be paid when a ﬁeld
dimension deﬁned by the position of jaws in the direction per-
pendicular to the leaves’ motion is smaller than the width of
all leaves being employed to dynamic plan delivery. In order
to reduce the dose leakage through a slit between adjacent
leaves, the jaws are usually positioned as close as possible to
the target. For that reason it is sometime observed that only
a very narrow part of the marginal leaf (for example 2mm)
is exposed, the rest (8mm) is covered by the jaw. We found
that the “tongue and groove” effect modiﬁes the local dose in
8 reports of practical oncology and radiotherapy 1 6 ( 2 0 1 1 ) 1–9
Fig. 11 – Exemplary results of veriﬁcation obtained for
Fig. 12 – Results of veriﬁcation obtained for H&N IMRT ﬁeldother tumour locations: (a) breast and (b) spine.
the situation described above much more intensively, which
has been presented in Fig. 13. However, the differences are
observed only at the top and at the bottom of the ﬁeld, very
close to the its border, decreasing the ﬁeld width.
5. Discussion
When the Sliding Window method is used, the diversiﬁcation
of dose distribution is obtained by smooth shifting of MLC
leaves during the treatment. The local dose value is propor-
tional to the time of exposure determined by opposite leaves
position. It is reasonable to monitor the total operating range
of MLC motion (including also low-dose regions placed in the
central part of the ﬁeld), ﬁrstly, because the low value of dose
is strongly determined by actual accuracy of MLC (dosimet-
rical leaf gap, minimal physical distance between opposite
leaves) and, secondly, because hypothetical irregularities in
leaf sequence observed for low-dose regions inﬂuence thewith collimator rotation 90◦: the irregularities observed
outside the body contour.
value of dose for high-dose parts of the ﬁeld. Paradoxically, it is
much easier for MLC to escalate the dose in a speciﬁed region
(the velocity of leaves is then low and the notable distances
between opposite leaves are observed) than to minimize it
(the leaves go faster and very close to each other). However,
while analysing the 3D CRT ﬁeld, the low-dose parts of the
ﬁeld, typically shielded by blocks or static MLC, are excluded.
In the case of the MCG ﬁeld, we suggest to perform the
analysis for a global image obtained as a superposition of
ﬂuencies acquired for all subﬁelds. Firstly, to make sure we
do not lose any information about low-dose regions (they
may be excluded when subﬁeld by subﬁeld veriﬁcation is
performed) and for the quantitative outcomes to become reli-
able. Secondly, the inﬂuence of dose leakage effect is much
more signiﬁcant for this area and produces additional dose
for organs-at-risk, which has to be controlled (e.g. spinal cord).
However, summingupof subﬁeldshas alsodisadvantages.Our
investigation shows that the dose errors appear often at the
positionwhere themotion of the leaf starts and also very close
to the place where it stops. In a hypothetical situation, one of
the subﬁelds in the junction area would generate a dose that
is too low,while the other onewould produce a dose that is too
high. Analyzing these subﬁelds separately would show differ-
ences, however summing them up leads to averaging errors
and the gamma veriﬁcation would unfortunately give good
results.
Depending on tumour shape and its location the signiﬁ-
cant differences between a level of intensity modulation are
observed. The static value of Dmin, arbitrarily chosen by the
examiner, can be only set for simple IMRTﬁelds, typically used
for a small area of irradiation (e.g. part of the brain or prostate),
when a quasi uniform dose in a total plane perpendicular to
the beam axis is expected. Changing the value of Dmin in this
case will not result in essential deviations in quantitative out-
comes of veriﬁcation, because all the contours obtained for
reports of practical oncology and radiotherapy 1 6 ( 2 0 1 1 ) 1–9 9
Fig. 13 – Example of prostate treatment: (a) screenshot of dMLC plan delivery – the leaves used for intensity modulation
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rave been highlighted (the red lines represent the position o
rregularities in the boundary parts of the ﬁeld.
ifferent Dmin are close to each other and nearly the same
rea is analysed. Realizing this condition, we came to the
onclusion that the ﬁeld contour should always be calculated
ndependently for each therapeutic ﬁeld to take under consid-
ration relatively the same number of points (compare Eq. (1))
nd a required algorithm has been designed and developed.
. Conclusion
s it was reported, the traditional dosimetric veriﬁcation of
ynamic plans, because of its quantitative outcomes, give
nly a partial picture of the quality of IMRT treatment. Com-
lex monitoring of dose delivery process is possible by owing
o images obtained as a result of the -bitmaps and corre-
ponding DRRs cross-examination. There have been at least
wo patients treated in our department, when the presented
olution allowed us to continue the radiotherapy, however the
uantitative outcomes of gamma veriﬁcation looked formally
ad. Because the IMRT planning is a relatively time consum-
ng procedure, a patient usually continues to be treated with
conventional 3D CRT plan, once the dosimetric veriﬁcation
f dynamic plan has failed.
The method is rather dedicated to head or head & neck
reatments, because the typically irradiated volumes are
trongly determined by the position of bone structures, which
re usually presented on DRR. It can be performed regardless
f whether portal dosimetry is available or not, however, the
onventional ﬁlm dosimetry is a very time consuming pro-
edure and makes the veriﬁcation of all therapeutic ﬁelds
ractically impossible.
Consider, that the presented algorithm is only the concep-
ion of treatment plan veriﬁcation. It allows to estimate the
ose accumulated by target and organs-at-risk during proper
MLC plan execution. The procedure assumes no signiﬁcant
hanges in patient’s anatomy (CT examination conformity)
nd, this way, it can be only used as an additional source ofs) and (b) result of the veriﬁcation – observe the
informationduringplan-to-treatment acceptationactivity.We
are currently investigating the proceedingswhichwill allow to
combine the map of the -index with the image acquired on
board (OBI, EPID, CBCT) during the treatment, which is espe-
cially promising for irradiation of soft and moving tissues (e.g.
the prostate).
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